The effectiveness of adding cognitive behavioural therapy aimed at changing lifestyle to managed diabetes care for patients with type 2 diabetes: design of a randomised controlled trial

Laura M C Welschen, Patricia van Oppen, Jacqueline M Dekker, Lex M Bouter, Wim A B Stalman, Giel Nijpels, Laura M C Welschen, Patricia van Oppen, Jacqueline M Dekker, Lex M Bouter, Wim A B Stalman, Giel Nijpels

Abstract

Background: In patients with type 2 diabetes, the risk for cardiovascular disease is substantial. To achieve a more favourable risk profile, lifestyle changes on diet, physical activity and smoking status are needed. This will involve changes in behaviour, which is difficult to achieve. Cognitive behavioural therapies focussing on self-management have been shown to be effective. We have developed an intervention combining techniques of Motivational Interviewing (MI) and Problem Solving Treatment (PST). The aim of our study is to investigate if adding a combined behavioural intervention to managed care, is effective in achieving changes in lifestyle and cardiovascular risk profile.

Methods: Patients with type 2 diabetes will be selected from general practices (n = 13), who are participating in a managed diabetes care system. Patients will be randomised into an intervention group receiving cognitive behaviour therapy (CBT) in addition to managed care, and a control group that will receive managed care only. The CBT consists of three to six individual sessions of 30 minutes to increase the patient's motivation, by using principles of MI, and ability to change their lifestyle, by using PST. The first session will start with a risk assessment of diabetes complications that will be used to focus the intervention. The primary outcome measure is the difference between intervention and control group in change in cardiovascular risk score. For this purpose blood pressure, HbA1c, total and HDL-cholesterol and smoking status will be assessed. Secondary outcome measures are quality of life, patient satisfaction, physical activity, eating behaviour, smoking status, depression and determinants of behaviour change. Differences between changes in the two groups will be analysed according to the intention-to-treat principle, with 95% confidence intervals. The power calculation is based on the risk for cardiovascular disease and we calculated that 97 patients should be included in every group.

Discussion: Cognitive behavioural therapy may improve self-management and thus strengthen managed diabetes care. This should result in changes in lifestyle and cardiovascular risk profile. In addition, we also expect an improvement of quality of life and patient satisfaction.

Trial registration: Current Controlled Trials ISRCTN12666286.

Figures

Figure 1
Figure 1
Design of the RCT.

References

    1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053. doi: 10.2337/diacare.27.5.1047.
    1. Wareham NJ, Wong MY, Day NE. Glucose intolerance and physical inactivity: the relative importance of low habitual energy expenditure and cardiorespiratory fitness. Am J Epidemiol. 2000;152:132–139. doi: 10.1093/aje/152.2.132.
    1. Wei M, Kampert JB, Barlow CE, Nichaman MZ, Gibbons LW, Paffenbarger RS, Jr., Blair SN. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA. 1999;282:1547–1553. doi: 10.1001/jama.282.16.1547.
    1. Wei M, Gibbons LW, Mitchell TL, Kampert JB, Lee CD, Blair SN. The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men. Ann Intern Med. 1999;130:89–96.
    1. Wei M, Gibbons LW, Kampert JB, Nichaman MZ, Blair SN. Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med. 2000;132:605–611.
    1. Foreyt JP, Poston WS. The challenge of diet, exercise and lifestyle modification in the management of the obese diabetic patient. Int J Obes Relat Metab Disord. 1999;23 Suppl 7:S5–11. doi: 10.1038/sj.ijo.0800955.
    1. Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet. 1999;353:617–622. doi: 10.1016/S0140-6736(98)07368-1.
    1. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383–393. doi: 10.1056/NEJMoa021778.
    1. Giminez Perez G, Gonzalez-Clemente JM, Mauricio D. Lifestyle interventions for preventing type 2 diabetes mellitus. Cochrane Database Syst Rev. 2001. p. CD003054.
    1. Wing RR, Hamman RF, Bray GA, Delahanty L, Edelstein SL, Hill JO, Horton ES, Hoskin MA, Kriska A, Lachin J, Mayer-Davis EJ, Pi-Sunyer X, Regensteiner JG, Venditti B, Wylie-Rosett J. Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res. 2004;12:1426–1434.
    1. Clark M, Hampson SE. Implementing a psychological intervention to improve lifestyle self-management in patients with type 2 diabetes. Patient Educ Couns. 2001;42:247–256. doi: 10.1016/S0738-3991(00)00128-2.
    1. Dunn AL, Marcus BH, Kampert JB, Garcia ME, Kohl HW, III, Blair SN. Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized trial. JAMA. 1999;281:327–334. doi: 10.1001/jama.281.4.327.
    1. Fisher EB, Walker EA, Bostrom A, Fischhoff B, Haire-Joshu D, Johnson SB. Behavioral science research in the prevention of diabetes: status and opportunities. Diabetes Care. 2002;25:599–606. doi: 10.2337/diacare.25.3.599.
    1. Wing RR, Goldstein MG, Acton KJ, Birch LL, Jakicic JM, Sallis JF, Jr., Smith-West D, Jeffery RW, Surwit RS. Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity. Diabetes Care. 2001;24:117–123. doi: 10.2337/diacare.24.1.117.
    1. Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet. 2004;363:1589–1597. doi: 10.1016/S0140-6736(04)16202-8.
    1. Nijpels G, Hoovers T, Dekker JM, Heine RJ. Regionaal georganiseerde diabeteszorg. Het Diabetes Zorgsysteem West-Friesland. Medisch Contact. 1998;53:1164–1166.
    1. Valk GD, Kriegsman DM, Nijpels G. Treatment of diabetes mellitus type 2 in family practice. Ned Tijdschr Geneeskd. 2001;145:1536–1540.
    1. Wiersma TJ, Heine RJ, Rutten GE. [Summary of the practice guideline 'Diabetes mellitus type 2' (first revision) of the Dutch College of General Practitioners] Ned Tijdschr Geneeskd. 1999;143:1688–1691.
    1. Renders CM, Valk GD, Griffin SJ, Wagner EH, Eijk VJT, Assendelft WJ. Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care. 2001;24:1821–1833. doi: 10.2337/diacare.24.10.1821.
    1. de Vries H, Dijkstra M, Kuhlman P. Self-efficacy: third factor besides attitude and subjective norm as a predictor of behavioral interventions. Health Education Research. 1988;3:273–282. doi: 10.1093/her/3.3.273.
    1. de Vries H, Backbier E, Kok G, Dijkstra M. The impact of social influences in the context of attitude, self-efficacy, intention and previous behavior as predictors of smoking onset. Journal Applied Social Psychology. 1995;25:237–257. doi: 10.1111/j.1559-1816.1995.tb01593.x.
    1. Kok GJ, de Vries H, Mudde AN, Strecher VJ. Planned health education and the role of self-efficacy: Dutch research. Health Education Research. 1991;6:231–238. doi: 10.1093/her/6.2.231.
    1. Bandura A. Social foundations of thought and action Englewood Cliffs (NJ): Prentice-Hall. 1986.
    1. Brug J, Lechner L, de Vries H. Psychosocial determinants of fruit and vegetable consumption. Appetite. 1995;25:285–296. doi: 10.1006/appe.1995.0062.
    1. de Vries H, Mudde AN, Dijkstra A, Willemsen MC. Differential beliefs, perceived social influences, and self-efficacy expectations among smokers in various motivational phases. Prev Med. 1998;27:681–689. doi: 10.1006/pmed.1998.0344.
    1. van Es SM, Nagelkerke AF, Colland VT, Scholten RJ, Bouter LM. An intervention programme using the ASE-model aimed at enhancing adherence in adolescents with asthma. Patient Educ Couns. 2001;44:193–203. doi: 10.1016/S0738-3991(00)00195-6.
    1. Miller WR, Rollnick S. Motivational Interviewing, preparing people for change. The Guilford Press, New York; 2002.
    1. Mynors-Wallis LM. Problem-solving treatment in general psychiatric practice. Advances in Psychiatric Treatment. 2001;7:417–425. doi: 10.1192/apt.7.6.417.
    1. D'Zurilla TJ, Goldfried MR. Problem solving and behavior modification. J Abnorm Psychol. 1971;78:107–126. doi: 10.1037/h0031360.
    1. D'Zurilla TJ, Nezu A. Social problem solving in adults. In: Kennedy PC, editor. Advances in cognitive-behavioral research and therapy. 1. New York, Academic Press; 1982. pp. 201–274.
    1. D'Zurilla TJ, Nezu AM. Problem-Solving Therapies. In: Dobson KS, editor. Handbook of Cognitive Behavioral Therapies. 2. Guilford Press; 2001. pp. 211–245.
    1. Mynors-Wallis LM, Gath DH, Day A, Baker F. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ. 2000;320:26–30. doi: 10.1136/bmj.320.7226.26.
    1. Thornett AM, Mynors-Wallis LM. Credibility of problem-solving therapy and medication for the treatment of depression among primary care patients. Med Sci Monit. 2002;8:CR193–CR196.
    1. Mynors-Wallis LM, Gath DH, Lloyd-Thomas AR, Tomlinson D. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ. 1995;310:441–445.
    1. Schreuders B, van Oppen P, van Marwijk HW, Smit JH, Stalman WA. Frequent attenders in general practice: problem solving treatment provided by nurses [ISRCTN51021015] BMC Fam Pract. 2005;6:42. doi: 10.1186/1471-2296-6-42.
    1. Pocock SJ. Methods of Randomization. In: S.J. P, editor. Clinical trials: A practical approach . Chichester, John Wiley & Sons; 1983. pp. 66–89.
    1. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Med Res Methodol. 2001;1:2. doi: 10.1186/1471-2288-1-2.
    1. Stevens RJ, Kothari V, Adler AI, Stratton IM. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56) Clin Sci (Lond) 2001;101:671–679. Erratum in: Clin Sci (Lond) 2002, 102: 679.
    1. Van Strien T, Frijters JER, Bergers GPA, Defares PB. The Dutch Eating Behaviour Questionnaire (DEBQ) for assessment of restrained, emotional and external eating behaviour. Int J Eat Disord. 1986;5:295–315.
    1. Wendel-Vos GC, Schuit AJ, Saris WH, Kromhout D. Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol. 2003;56:1163–1169. doi: 10.1016/S0895-4356(03)00220-8.
    1. de Vries H. Determinanten van gedrag. In: Damoiseaux V, van der Molen HT and Kok GJ, editor. Gezondheidsvoorlichting en gedragsverandering. Assen, Van Gorcum; 1993. pp. 109–132.
    1. EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy. 1990;16:199–208. doi: 10.1016/0168-8510(90)90421-9.
    1. Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53–72. doi: 10.1016/0168-8510(96)00822-6.
    1. Radloff LS. The CES-D scale: a self-reported depression scale for research in the general population. Appl Psych Meas. 1977;1:385–401. doi: 10.1177/014662167700100306.
    1. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.
    1. Pouwer F, Snoek FJ. Patients' Evaluation of the Quality of Diabetes Care (PEQD): development and validation of a new instrument. Qual Saf Health Care. 2002;11:131–136. doi: 10.1136/qhc.11.2.131.
    1. Diggle PJ, Liang KY, Zeger SL. Analysis of longitudinal data. New York, Oxford University Press; 1994.
    1. Leyland AH, Goldstein H. Multilevel modelling of health statistics. New York, John Wiley & Sons, LTD; 2001.
    1. Egger M, Smith GD. Bias in location and selection of studies. BMJ. 1998;316:61–66.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren